Sinopep-Allsino Bio Pharmaceutical Co., Ltd.SSE: 688076

Announcement on Using Idle Raised Funds for Cash Management

Jan 17, 2026 · Issued by Sinopep-Allsino Bio Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 17, 2026

On 6ix: 6ix.com/news/announcement-on-using-idle-raised-funds-for-cash-management-29

Announcement on Using Idle Raised Funds for Cash Management

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix

Earlier from Sinopep-Allsino Bio Pharmaceutical

Announcement on Progress in Signing a Major Daily Operation ContractDec 31, 2025
Announcement on Receiving the Decision of Administrative PenaltyDec 18, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Atosiban Acetate InjectionDec 10, 2025
Announcement on Voluntary Disclosure of Agomelatine Tablets Prospective Winning of the 11th National Centralized Drug ProcurementOct 29, 2025
Report for Q3 2025Oct 23, 2025

Later from Sinopep-Allsino Bio Pharmaceutical

JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. Earnings Preannouncement for 2025Jan 31
JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.: Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Feb 3
Announcement on Voluntary Disclosure of Passing GMP Compliance Inspection for DrugsFeb 4
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2026Apr 8

All Sinopep-Allsino Bio Pharmaceutical news releases

Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.

Follow Sinopep-Allsino Bio Pharmaceutical